Skip to content

Clinical trials

Phase 2 Glioma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: United States Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20026
20036
20043
200510
20068
200714
200812
200914
201014
20117
20124
20135
20145
20154
201610
201720
20189
201911
20206
20215
20225
20233
20248
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Terminated39
Active, not recruiting19
Recruiting17
Withdrawn8
Unknown status7
Not yet recruiting3
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
Duke University23
Memorial Sloan Kettering Cancer Center7
Dana-Farber Cancer Institute6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
University of California, San Francisco6
NYU Langone Health5
Wake Forest University Health Sciences5
Katy Peters4
Washington University School of Medicine4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma227
Glioblastoma126
Brain Neoplasms96
Astrocytoma84
Oligodendroglioma59
Gliosarcoma55
Central Nervous System Neoplasms48
Ependymoma30
Medulloblastoma21
Sarcoma16

Trials

Showing 1 to 25 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.